Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Prognostic impact of mutations in the DNA methylation pathway on clinical outcomes in acute myeloid leukemia: A retrospective cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

EZEmily C. ZaborCleveland ClinicDNDaniel Paul NurseCleveland ClinicHAHasan AbuamshaCleveland Clinic

Discussion

Loading...

Member takes

Overview

Retrospective cohort study reveals somatic mutations in dnmt3a influence event-free survival in treated acute myeloid leukemia patients, indicating their prognostic value.

Key Points

  • This research focuses on the prognostic significance of mutations in the DNA methylation pathway for newly diagnosed acute myeloid leukemia patients.
  • Conducted a retrospective cohort study of adult newly diagnosed AML patients from 2015–2023
  • Analyzed baseline demographics, treatments, and molecular profiles using next-generation sequencing
  • Utilized multivariable Cox regression to examine relationships between gene mutations and clinical outcomes.
  • DNMT3A mutations linked to improved event-free survival (EFS) but not overall survival (OS)
  • WT1 mutations associated with inferior EFS
  • IDH1 mutations predictive of higher clinical response without affecting survival

Cite This Study

Zabor et al. (2025) studied this question.

synapsesocial.com/papers/69362f6c4fa91c937236e040https://doi.org/10.1182/blood-2025-5254
View Full Paper
Ask AI
Bookmark
Share